Country Trust Bank Vertex Pharmaceuticals Inc Transaction History

Country Trust Bank

$3.86 Billion
Q4 2024

A detailed history of Country Trust Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Country Trust Bank holds 83,602 shares of VRTX stock, worth $40.5 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

83,602

Previous 94,091 11.15%

Holding current value

$40.5 Million

Previous $43.8 Million 23.06%

% of portfolio

0.87%

Previous 1.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$396.64 - $516.74 $4.16 Million - $5.42 Million	-10,489 Reduced 11.15%	83,602 $33.7 Million
Q3 2024 Oct 08, 2024	SELL	$460.0 - $505.78 $115,000 - $126,445	-250 Reduced 0.26%	94,091 $43.8 Million
Q2 2024 Jul 12, 2024	BUY	$392.81 - $485.53 $6,284 - $7,768	16 Added 0.02%	94,341 $44.2 Million
Q1 2024 Apr 16, 2024	SELL	$407.69 - $446.08 $3.2 Million - $3.51 Million	-7,859 Reduced 7.69%	94,325 $39.4 Million
Q4 2023 Jan 08, 2024	SELL	$343.0 - $410.68 $6.04 Million - $7.23 Million	-17,605 Reduced 14.7%	102,184 $41.6 Million
Q3 2023 Oct 10, 2023	SELL	$338.18 - $362.46 $4.56 Million - $4.88 Million	-13,477 Reduced 10.11%	119,789 $41.7 Million
Q2 2023 Jul 12, 2023	SELL	$314.42 - $351.91 $1.39 Million - $1.56 Million	-4,435 Reduced 3.22%	133,266 $46.9 Million
Q1 2023 Apr 13, 2023	SELL	$283.23 - $323.1 $2.75 Million - $3.14 Million	-9,722 Reduced 6.59%	137,701 $43.4 Million
Q4 2022 Jan 18, 2023	SELL	$285.76 - $321.48 $268,614 - $302,191	-940 Reduced 0.63%	147,423 $0
Q3 2022 Oct 20, 2022	BUY	$273.83 - $305.53 $4.86 Million - $5.42 Million	17,752 Added 13.59%	148,363 $43 Million
Q2 2022 Jul 12, 2022	SELL	$234.96 - $292.55 $1.65 Million - $2.06 Million	-7,027 Reduced 5.11%	130,611 $36.8 Million
Q1 2022 Apr 25, 2022	SELL	$221.42 - $260.97 $9.31 Million - $11 Million	-42,030 Reduced 23.39%	137,638 $35.9 Million
Q4 2021 Jan 26, 2022	BUY	$177.01 - $223.45 $3.41 Million - $4.31 Million	19,269 Added 12.01%	179,668 $39.5 Million
Q3 2021 Oct 26, 2021	BUY	$181.39 - $202.99 $11.9 Million - $13.3 Million	65,631 Added 69.25%	160,399 $29.1 Million
Q2 2021 Jul 19, 2021	BUY	$187.49 - $221.1 $17.7 Million - $20.9 Million	94,588 Added 52548.89%	94,768 $19.1 Million
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $37,261 - $49,696	180 New	180 $43,000
Q1 2019 Apr 17, 2019	SELL	$163.73 - $194.7 $2,292 - $2,725	-14 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$151.91 - $192.21 $911 - $1,153	6 Added 75.0%	14 $2,000
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $4,371 - $5,098	-30 Reduced 78.95%	8 $1,000
Q1 2018 May 08, 2018	BUY	$151.6 - $177.13 $5,760 - $6,730	38 New	38 $6,000

Others Institutions Holding VRTX

# of Institutions

1,753

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.

Account

Country Trust Bank Vertex Pharmaceuticals Inc Transaction History